DCF — MERCY MEDICAL CENTER
Enterprise Value: $-650.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-650.6M
Enterprise Value
$-201.9M
PV of Cash Flows
$-448.7M
PV of Terminal Value
$-722.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $290.9M | $-42.7M | -15.0% | $-55.0M | $-50.0M |
| Year 2 | $299.6M | $-40.9M | -14.0% | $-53.6M | $-44.3M |
| Year 3 | $308.6M | $-39.1M | -13.0% | $-52.2M | $-39.2M |
| Year 4 | $317.8M | $-38.7M | -12.0% | $-52.1M | $-35.6M |
| Year 5 | $327.4M | $-39.0M | -12.0% | $-52.9M | $-32.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-650.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$282.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.15168159121797248
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5